Acumen Pharmaceuticals, Inc.ABOSNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-2.20
Operating CF/Share$-2.04
Free CF/Share$-2.04
Cash/Share$2.09
Book Value/Share$1.54
Tangible Book/Share$1.54
Equity/Share$1.54
Interest Debt/Share$0.58
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$157.49M
Enterprise Value$141.49M
P/E Ratio-1.18P/S Ratio0.00P/OCF Ratio-1.27
P/FCF Ratio-1.27
P/B Ratio1.69P/TB Ratio1.69
EV/Sales0.00EV/EBITDA-1.10
Graham Valuation
Graham Number--
Graham Net-Net$1.29
Profitability
Earnings Yield-84.67%FCF Yield-78.57%ROE-97.41%ROIC-111.47%Return on Tangible Assets-93.78%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.07%
CapEx/Revenue0.00%
CapEx/Depreciation0.65
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.33Debt/Assets0.22Debt/Market Cap0.20
Net Debt/EBITDA0.12
Current Ratio6.02Interest Coverage-33.12xIncome Quality0.93Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding5658 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.06x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$93.14M
Working Capital$110.20M
Invested Capital$110.52M
Intangibles/Assets0.02%